{"nct_id":"NCT04198766","title":"Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2019-12-10","start_date_type":"ACTUAL","primary_completion_date":"2026-10-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INBX"]}